Superimposition evaluation of ecdysteroid agonist chemotypes through multidimensional QSAR
暂无分享,去创建一个
[1] A. Hopfinger,et al. Construction of 3D-QSAR Models Using the 4D-QSAR Analysis Formalism , 1997 .
[2] Toshio Fujita,et al. Classical and Three-Dimensional QSAR in Agrochemistry , 1995 .
[3] Anton J. Hopfinger,et al. 4D-QSAR Analysis of a Set of Ecdysteroids and a Comparison to CoMFA Modeling , 2001, J. Chem. Inf. Comput. Sci..
[4] A J Hopfinger,et al. Extraction of pharmacophore information from high-throughput screens. , 2000, Current opinion in biotechnology.
[5] Kazunari Hattori,et al. Molting hormonal and larvicidal activities of aliphatic acyl analogs of dibenzoylhydrazine insecticides , 1997, Steroids.
[6] 城所 良明,et al. The Salk Institute for Biological Studies(話題) , 1975 .
[7] Exploring QSAR. , 1995, Environmental science & technology.
[8] Peter Karlson,et al. Ecdysone : from chemistry to mode of action , 1989 .
[9] H. Kubinyi,et al. 3D QSAR in drug design. , 2002 .
[10] X. Breakefield,et al. Critical issues in gene therapy for neurologic disease. , 2002, Human gene therapy.
[11] D. Moras,et al. A new model for 20‐hydroxyecdysone and dibenzoylhydrazine binding: A homology modeling and docking approach , 2000, Protein science : a publication of the Protein Society.
[12] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[13] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.
[14] W. Hoppe,et al. Zur Chemie des Ecdysons, VII: Die Kristall‐ und Molekülstrukturanalyse des Insektenverpuppungshormons Ecdyson mit der automatisierten Faltmolekülmethode , 1965 .
[15] Hugo Kubinyi,et al. 3D QSAR in drug design : theory, methods and applications , 2000 .
[16] N. Jess,et al. Reporter-linked monitoring of transgene expression in living cells using the ecdysone-inducible promoter system. , 2000, European journal of cell biology.
[17] Paul S. Charifson,et al. Practical Application of Computer-Aided Drug Design , 1997 .
[18] Vincent Laudet,et al. The nuclear receptor factsbook , 2002 .
[19] T. Bestor. Gene silencing as a threat to the success of gene therapy. , 2000, The Journal of clinical investigation.
[20] R. Cramer,et al. Validation of the general purpose tripos 5.2 force field , 1989 .
[21] Robert E. Hormann,et al. Theoretical Study of the Structure and Rotational Flexibility of Diacylhydrazines: Implications for the Structure of Nonsteroidal Ecdysone Agonists and Azapeptides , 1996 .
[23] V. Henrich,et al. The Ecdysone Receptor Puzzle , 1999 .
[24] M. Akamatsu,et al. Quantitative structure-activity studies of insect growth regulators XIV. Three-dimensional quantitative structure-activity relationship of ecdysone agonists including dibenzoylhydrazine analogs , 1998 .
[25] K. D. Wing,et al. RH 5849, a Nonsteroidal Ecdysone Agonist: Effects on Larval Lepidoptera. , 1988, Science.
[26] David A. Agard,et al. The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.
[27] K. D. Wing. RH 5849, a nonsteroidal ecdysone agonist: effects on a Drosophila cell line. , 1988, Science.
[28] L. Dinan,et al. Assessment of a microplate-based bioassay for the detection of ecdysteroid-like or antiecdysteroid activities , 1993 .
[29] D. Balicki,et al. Gene Therapy of Human Disease , 2002, Medicine.